Cognition Therapeutics (CGTX) Institutional Ownership $0.38 -0.01 (-2.72%) Closing price 04:00 PM EasternExtended Trading$0.38 -0.01 (-2.17%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cognition Therapeutics (NASDAQ:CGTX)CurrentInstitutional OwnershipPercentage43.35%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$7.09MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.84M Get CGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cognition Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGTX Institutional Buying and Selling by Quarter Remove Ads Cognition Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Two Sigma Investments LP53,691$38K0.0%+372.2%0.129% 2/14/2025Voss Capital LP500,000$351K0.0%N/A1.203% 2/12/2025Geode Capital Management LLC352,348$247K0.0%+8.9%0.848% 2/11/2025Virtu Financial LLC80,180$56K0.0%+40.1%0.193% 2/10/2025BIOS Capital Management LP6,000,000$4.21M4.5%N/A14.441% 2/7/2025CM Management LLC200,000$140K0.1%-20.0%0.481% 2/3/2025Sigma Planning Corp614,490$431K0.0%+211.6%1.479% 1/17/2025SG Americas Securities LLC37,108$26K0.0%N/A0.089% 11/20/2024Virtu Financial LLC57,231$27K0.0%N/A0.138% 11/4/2024Sigma Planning Corp197,190$92K0.0%+14.6%0.491% Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2024Mercer Global Advisors Inc. ADV95,951$159K0.0%+33.4%0.240% 8/9/2024Renaissance Technologies LLC89,718$149K0.0%-42.4%0.224% 8/7/2024AIGH Capital Management LLC300,766$499K0.2%-84.1%0.751% 8/2/2024CM Management LLC200,000$332K0.3%+14.3%0.499% 7/16/2024Bangor Savings Bank34,019$56K0.0%+41.6%0.085% 5/16/2024Levin Capital Strategies L.P.30,000$55K0.0%N/A0.075% 5/16/2024AWM Investment Company Inc.650,000$1.18M0.2%N/A1.623% 5/14/2024Carlson Capital L P213,995$389K0.0%-10.1%0.534% 5/14/2024CM Management LLC175,000$318K0.3%N/A0.437% 5/10/2024Tocqueville Asset Management L.P.26,000$47K0.0%N/A0.065% 5/8/2024Hohimer Wealth Management LLC225,000$410K0.1%N/A0.562% 3/5/2024Twin Focus Capital Partners LLC93,372$173K0.0%N/A0.291% 2/8/2024Texas Capital Bank Wealth Management Services Inc55,395$102K0.0%N/A0.172% 2/1/2024Sigma Planning Corp28,550$53K0.0%N/A0.089% 10/23/2023Steward Financial Group LLC40,874$58K0.0%N/A0.135% 7/28/2023Voss Capital LLC60,222$110K0.0%-62.4%0.206% 5/12/2023Voss Capital LLC159,973$317K0.0%-4.2%0.546% 5/12/2023FCA Corp TX51,471$102K0.0%N/A0.176% 2/16/2023AIGH Capital Management LLC2,037,853$4.28M1.4%+155.3%7.030% 2/13/2023Northeast Financial Consultants Inc24,500$51K0.0%N/A0.085% 2/13/2023Voss Capital LLC166,903$350K0.1%-23.8%0.576% 2/13/2023Financial Partners Capital Management LLC14,228$30K0.0%N/A0.049% 2/7/2023Commonwealth Equity Services LLC189,307$397K0.0%-13.6%0.653% 2/6/2023Neumann Capital Management LLC33,382$70K0.0%N/A0.115% 1/31/2023Kestra Advisory Services LLC50,618$106K0.0%+237.5%0.175% 1/20/2023 Diligent Investors LLC20,000$42K0.0%-34.5%0.069% 12/13/2022Perigon Wealth Management LLC36,900$70K0.0%-70.0%0.127% 11/15/2022Carlson Capital L P100,000$190K0.0%N/A0.440% 11/14/2022Worth Venture Partners LLC200,188$380K0.2%-12.3%0.881% 11/10/2022Rock Creek Group LP50,000$95K0.0%-37.3%0.220% Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment…11/2/2022Voss Capital LLC219,100$416K0.1%-29.2%0.965% 11/1/2022P.A.W. Capital Corp100,000$190K0.3%-25.9%0.440% 10/12/2022 Wealth Alliance Advisory Group LLC18,500$35K0.0%N/A0.081% 8/13/2022Voss Capital LLC309,472$653K0.2%+1,070.5%1.363% 8/13/2022Prosight Management LP120,198$254K0.2%-49.9%0.532% 8/11/2022Perigon Wealth Management LLC122,846$259K0.0%N/A0.544% 8/8/2022Rock Creek Group LP79,751$170K0.0%+201.6%0.353% 8/1/2022Castle Wealth Management LLC43,380$92K0.1%N/A0.192% 7/19/2022Commonwealth Equity Services LLC214,961$453K0.0%+1,447.6%0.951% 7/13/2022P.A.W. Capital Corp135,000$285K0.4%+12.5%0.597% 5/17/2022Prosight Management LP240,080$660K0.4%-20.5%1.062% 5/4/2022Commonwealth Equity Services LLC13,890$38K0.0%N/A0.061% 4/26/2022 Diligent Investors LLC30,520$84K0.0%N/A0.135% 4/26/2022Kestra Advisory Services LLC238,666$656K0.0%+150.9%1.057% 4/21/2022P.A.W. Capital Corp120,000$330K0.3%+20.0%0.531% 4/14/2022Bangor Savings Bank18,496$51K0.0%N/A0.082% 2/10/2022B. Riley Financial Inc.30,904$195K0.0%N/A0.140% 2/10/2022American Financial Group Inc.205,000$1.30M0.4%N/A0.930% 2/10/2022AIGH Capital Management LLC25,496$161K0.0%N/A0.116% 2/10/2022P.A.W. Capital Corp100,000$632K0.6%N/A0.454% (Data available from 1/1/2016 forward)Remove Ads CGTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGTX shares? During the previous two years, 22 institutional investors and hedge funds held shares of Cognition Therapeutics. The most heavily invested institutionals were BIOS Capital Management LP ($4.21M), AWM Investment Company Inc. ($1.18M), AIGH Capital Management LLC ($499K), Sigma Planning Corp ($431K), Hohimer Wealth Management LLC ($410K), Carlson Capital L P ($389K), and Voss Capital LP ($351K).Learn more on CGTX's institutional investors. What percentage of Cognition Therapeutics stock is owned by institutional investors? 43.35% of Cognition Therapeutics stock is owned by institutional investors. Learn more on CGTX's institutional investor holdings. Which institutional investors have been buying Cognition Therapeutics stock? Of the 18 institutional investors that purchased Cognition Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($6M), AWM Investment Company Inc. ($650K), Voss Capital LP ($500K), Sigma Planning Corp ($470.90K), Hohimer Wealth Management LLC ($225K), CM Management LLC ($200K), and Twin Focus Capital Partners LLC ($93.37K). How much institutional buying is happening at Cognition Therapeutics? Institutional investors have bought a total of 8,565,376 shares in the last 24 months. This purchase volume represents approximately $7.58M in transactions. Which Cognition Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cognition Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($1.60M), Voss Capital LLC ($106.68K), Renaissance Technologies LLC ($65.98K), CM Management LLC ($50K), and Carlson Capital L P ($24.01K). How much institutional selling is happening at Cognition Therapeutics? Institutional investors have sold a total of 1,843,175 shares in the last 24 months. This volume of shares sold represents approximately $3.03M in transactions. Related Companies Alector Institutional Ownership BioHarvest Sciences Institutional Ownership Kyverna Therapeutics Institutional Ownership XBiotech Institutional Ownership Tiziana Life Sciences Institutional Ownership Oramed Pharmaceuticals Institutional Ownership OptiNose Institutional Ownership Coya Therapeutics Institutional Ownership Zentalis Pharmaceuticals Institutional Ownership Vor Biopharma Institutional Ownership This page (NASDAQ:CGTX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
